| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 08/02/2007 | US20070179163 Process for the preparation of risperidone |
| 08/02/2007 | US20070179158 2,6-Disubstituted piperiddines as modulators |
| 08/02/2007 | US20070179150 Nitrosated proton pump inhibitors, compositions and methods of use |
| 08/02/2007 | US20070179142 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 08/02/2007 | US20070179138 6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives |
| 08/02/2007 | US20070179118 Use as inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example |
| 08/02/2007 | US20070178512 Modified carbocyanine dyes and their conjugates |
| 08/02/2007 | US20070178511 Modified carbocyanine dyes and their conjugates |
| 08/02/2007 | US20070178052 Delivery of opioids through an inhalation route |
| 08/02/2007 | DE102006002649A1 New aza-heterocycle compounds are tyrosine kinase inhibitors useful to treat and/or prevent e.g. cancer, tumor growth, tumor angiogenesis, arteriosclerosis, diabetic retinopathy and inflammation diseases |
| 08/02/2007 | CA2641120A1 Process for the stereoselective preparation of alcohols from alpha, beta- insaturated compounds |
| 08/02/2007 | CA2637335A1 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 08/02/2007 | CA2636701A1 Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors |
| 08/02/2007 | CA2636696A1 Inhibitors of tyrosine kinases and uses thereof |
| 08/02/2007 | CA2635126A1 Tetrahydropyrane antibiotics |
| 08/02/2007 | CA2627692A1 Spiro imidazole derivatives as ppar modulators |
| 08/01/2007 | EP1813616A2 Pyrazoloquinolines with immunomodulating activity |
| 08/01/2007 | EP1813613A1 Novel fused imidazole derivative |
| 08/01/2007 | EP1812437A1 Process for making a non-nucleoside hiv-1 reverse transcriptase inhibitor |
| 08/01/2007 | EP1812436A1 Metabolites of certain [1,4]diazepino[6,7,1-ij]quinoline derivatives and methods of preparation and use thereof |
| 08/01/2007 | EP1812435A2 Preparation of tadalafil intermediates |
| 08/01/2007 | EP1812434A2 1,7-naphthyridines as pde4 inhibitors |
| 08/01/2007 | EP1812433A1 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds |
| 08/01/2007 | EP1812403A2 Pyrazolobenzamides and derivatives as factor xa inhibitors |
| 08/01/2007 | EP1812388A1 Sulfonamide pert-substituted bicyclics for occlusive artery disease |
| 08/01/2007 | EP1812005A2 Lactam compounds and their use as pharmaceuticals |
| 08/01/2007 | EP1812004A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
| 08/01/2007 | EP1812003A1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors |
| 08/01/2007 | EP1811845A2 Substituted biaryl quinolin-4-ylamine analogues |
| 08/01/2007 | EP1487822B1 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors |
| 08/01/2007 | EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 08/01/2007 | EP1355904B1 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 08/01/2007 | EP1294698B1 Fused azepine derivatives and their use as antidiuretic agents |
| 08/01/2007 | EP1259235B1 Tyrosine kinase inhibitors |
| 08/01/2007 | EP1187592B1 Alpha v integrin receptor antagonists |
| 08/01/2007 | CN1329394C Novel imidazole derivatives, production method thereof and use thereof |
| 08/01/2007 | CN1329392C Substituted pyrazoles |
| 08/01/2007 | CN101010323A Bicyclononene derivatives as renin inhibitors |
| 08/01/2007 | CN101010322A Pyrrolo[3,2-C]pyridine derivatives and processes for the preparation thereof |
| 08/01/2007 | CN101010321A Pyrrolo[3,2-B]pyridine derivatives and processes for the preparation thereof |
| 08/01/2007 | CN101010302A Sigma receptor inhibitors |
| 08/01/2007 | CN101007815A Pyrrolehexa-heterocyclic compound and pharmaceutical use thereof |
| 08/01/2007 | CN101007814A Pyrrolehexa-heterocyclic compound and pharmaceutical use thereof |
| 08/01/2007 | CN101007805A 6-cyano-1,1-disubstituted alkoxy(alkylsulphide)-7-[(carbalkoxy)-methyl]-5-oxo-delta6(8)-tetrahydro indolizine compound preparation method |
| 08/01/2007 | CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/01/2007 | CN101007802A Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 07/31/2007 | US7250516 Phenylalanine derivatives |
| 07/31/2007 | US7250514 Histone deacetylase inhibitors |
| 07/31/2007 | US7250424 Fab I inhibitors |
| 07/31/2007 | US7250417 Arylmethyl triazolo- and imidazopyrazines as c-Met inhibitors |
| 07/31/2007 | CA2412596C Cyclic gmp-specific phosphodiesterase inhibitors |
| 07/31/2007 | CA2270964C Benzonaphthyridines as bronchial therapeutics |
| 07/31/2007 | CA2175212C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 07/31/2007 | CA2121253C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 07/26/2007 | WO2007084667A2 Fused heterobicyclic kinase inhibitors |
| 07/26/2007 | WO2007084557A2 Azaindoles useful as inhibitors of janus kinases |
| 07/26/2007 | WO2007084532A2 Combination therapy with parp inhibitors |
| 07/26/2007 | WO2007084455A1 Hydantoin compounds for the treatment of inflammatory disorders |
| 07/26/2007 | WO2007084391A2 Thiazole compounds as protein kinase b ( pkb) inhibitors |
| 07/26/2007 | WO2007082910A1 Dicarbonylic compounds with antibacterial activity |
| 07/26/2007 | WO2007082873A1 Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase |
| 07/26/2007 | WO2007082811A2 Tetrabenzodiazadiketoperylene colourants in ir-reflective coatings and plastics |
| 07/26/2007 | WO2007082806A1 Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of alzheimer’s disease via gaba receptors |
| 07/26/2007 | WO2007067478A3 P38 kinase inhibiting agents |
| 07/26/2007 | WO2007065942A3 Bis-heterocyclic imidazolyl compounds |
| 07/26/2007 | WO2007062175A3 Spiro-substituted tricyclic heterocycles cxcr3 antagonists |
| 07/26/2007 | WO2007017762A3 Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections |
| 07/26/2007 | WO2006107853A3 Pyrazolopyridine-1,4-diamines and analogs thereof |
| 07/26/2007 | WO2005105092A3 3,3-disubstituted tetrahydropyranyl cyclopentyl amide modulators of chemokine receptor activity |
| 07/26/2007 | US20070173542 Peptide deformylase inhibitors |
| 07/26/2007 | US20070173537 Indazole compound and pharmaceutical use thereof |
| 07/26/2007 | US20070173527 Histone deacetylase inhibitors |
| 07/26/2007 | US20070173526 Compounds and methods for treating dyslipidemia |
| 07/26/2007 | US20070173525 Receptor or non-receptor types; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, agents; retinal vascularization |
| 07/26/2007 | US20070173524 N-[2-(Indol-3-yl)ethyl]-S-methyl-dithiocarbamate; N-[2-(benzo[b]thiophen-3-yl)ethyl]-S-methyl-dithiocarbamate; N-[2-(indol-3-yl)ethyl]-S[(naphth-2-yl)methyl]-dithiocarbamate; anticarcinogenic agents; free of brassinin |
| 07/26/2007 | US20070173513 Imidazole compounds |
| 07/26/2007 | US20070173512 Imidazole compounds |
| 07/26/2007 | US20070173510 Imidazole compounds |
| 07/26/2007 | US20070173509 Imidazole compounds |
| 07/26/2007 | US20070173508 Tricyclic inhibitors of 5-lipoxygenase |
| 07/26/2007 | US20070173507 Dairyl-substituted five-membered heterocycle derivative |
| 07/26/2007 | US20070173503 Novel 4-benzimidazol-2-ylpyridazin-3-one derivatives |
| 07/26/2007 | US20070172420 Ligands |
| 07/26/2007 | CA2637385A1 Compounds for the treatment of inflammatory disorders |
| 07/26/2007 | CA2637198A1 Hydantoin compounds for the treatment of inflammatory disorders |
| 07/26/2007 | CA2637052A1 Dicarbonylic compounds with antibacterial activity |
| 07/26/2007 | CA2636189A1 Azaindoles useful as inhibitors of janus kinases |
| 07/26/2007 | CA2636112A1 Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine derivatives useful for the treatment of alzheimer's disease via gaba receptors |
| 07/26/2007 | CA2635899A1 Fused heterobicyclic kinase inhibitors |
| 07/26/2007 | CA2635691A1 Combination therapy with parp inhibitors |
| 07/26/2007 | CA2630273A1 Heterocyclylalkyl derivatives as inhibitors of histone deacetylase |
| 07/25/2007 | EP1809631A1 Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1h-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
| 07/25/2007 | EP1809630A1 4-amino-5-oxo-8-phenyl-5h-pyrido-[2,3-d]-pyrimidine derivatives as tyrosine kinase and raf kinase inhibitors for the treatment of tumours |
| 07/25/2007 | EP1809629A1 N,n'-diphenyl urea derivatives suitable as kinase inhibitors |
| 07/25/2007 | EP1809628A1 Phenylurea derivatives used as inhibitors of tyrosinkinase for treating tumors |
| 07/25/2007 | EP1809627A1 Synthesis of heteroaryl acetamides from reaction mixtures having reduced water content |
| 07/25/2007 | EP1809607A1 Sulfonyl benzimidazole derivatives |
| 07/25/2007 | EP1809282A2 Thiadiazole compounds and methods of use |
| 07/25/2007 | EP1713802B1 2,4-dioxopyrimidine-based mesoionic pigments |
| 07/25/2007 | EP1448562B1 Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |